BRPI0811621A2 - Oligonucleotídeos de classe a com potência imunoestimuladora, composição contendo os mesmos e uso da referida composição - Google Patents

Oligonucleotídeos de classe a com potência imunoestimuladora, composição contendo os mesmos e uso da referida composição

Info

Publication number
BRPI0811621A2
BRPI0811621A2 BRPI0811621-0A2A BRPI0811621A BRPI0811621A2 BR PI0811621 A2 BRPI0811621 A2 BR PI0811621A2 BR PI0811621 A BRPI0811621 A BR PI0811621A BR PI0811621 A2 BRPI0811621 A2 BR PI0811621A2
Authority
BR
Brazil
Prior art keywords
composition
immunostimulating
oligonucleotides
class
power
Prior art date
Application number
BRPI0811621-0A2A
Other languages
English (en)
Portuguese (pt)
Inventor
Arthur M Krieg
Eugen Uhlmann
Joerg Vollmer
Original Assignee
Coley Pharm Group Inc
Coley Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coley Pharm Group Inc, Coley Pharm Gmbh filed Critical Coley Pharm Group Inc
Publication of BRPI0811621A2 publication Critical patent/BRPI0811621A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0811621-0A2A 2007-05-17 2008-05-15 Oligonucleotídeos de classe a com potência imunoestimuladora, composição contendo os mesmos e uso da referida composição BRPI0811621A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93058007P 2007-05-17 2007-05-17
PCT/IB2008/001199 WO2008142509A2 (en) 2007-05-17 2008-05-15 Class a oligonucleotides with immunostimulatory potency

Publications (1)

Publication Number Publication Date
BRPI0811621A2 true BRPI0811621A2 (pt) 2014-10-21

Family

ID=39720158

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811621-0A2A BRPI0811621A2 (pt) 2007-05-17 2008-05-15 Oligonucleotídeos de classe a com potência imunoestimuladora, composição contendo os mesmos e uso da referida composição

Country Status (15)

Country Link
US (1) US20100285041A1 (enExample)
EP (1) EP2160199A2 (enExample)
JP (1) JP2009035530A (enExample)
KR (1) KR20100010509A (enExample)
CN (1) CN101678098A (enExample)
AR (1) AR066626A1 (enExample)
AU (1) AU2008252577A1 (enExample)
BR (1) BRPI0811621A2 (enExample)
CA (1) CA2687441A1 (enExample)
IL (1) IL202096A0 (enExample)
MX (1) MX2009012482A (enExample)
RU (1) RU2009142211A (enExample)
TW (1) TW200916115A (enExample)
WO (1) WO2008142509A2 (enExample)
ZA (1) ZA200908062B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030026782A1 (en) * 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US7276489B2 (en) * 2002-10-24 2007-10-02 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
EP3006043B1 (en) 2002-04-04 2019-05-29 Zoetis Belgium S.A. Immunostimulatory g,u-containing oligoribonucleotides
US20040053880A1 (en) 2002-07-03 2004-03-18 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
AR040996A1 (es) 2002-08-19 2005-04-27 Coley Pharm Group Inc Acidos nucleicos inmunoestimuladores
SI2241325T1 (sl) 2002-10-29 2012-05-31 Coley Pharm Group Inc Uporaba CPG oligonukleotidov pri zdravljenju okužbe z virusom hepatitisa C
BRPI0416079A (pt) 2003-10-30 2007-01-02 Coley Pharm Gmbh análogos de oligonucleotìdeos de classe c com uma potência imunoestimuladora aumentada
KR101251707B1 (ko) 2006-09-27 2013-04-11 콜리 파마슈티칼 게엠베하 면역 자극 활성이 증강된 소수성 Ｔ 유사체를 함유하는 ＣｐＧ 올리고뉴클레오티드 유사체
CA2800158C (en) * 2010-05-28 2020-07-21 Coley Pharmaceutical Group, Inc. Vaccines comprising cholesterol and cpg as sole adjuvant-carrier molecules
EP2471926A3 (en) * 2010-12-30 2012-07-11 Intervet International BV Immunostimulatory oligodeoxynucleotides
KR102712879B1 (ko) * 2012-07-13 2024-10-04 웨이브 라이프 사이언시스 리미티드 키랄 제어
EP3238727B1 (en) * 2014-12-25 2023-01-18 National Institutes of Biomedical Innovation, Health and Nutrition Non-aggregating immunostimulatory oligonucleotides
TW201639583A (zh) * 2015-03-20 2016-11-16 國立研究開發法人醫藥基盤 健康 營養研究所 具有免疫賦活活性之含有ＣｐＧ－間隔基－寡核苷酸複合體及其用途
US12246031B2 (en) 2018-02-13 2025-03-11 Checkmate Pharmaceuticals, Inc. Compositions and methods for tumor immunotherapy
AU2019251421B2 (en) 2018-04-09 2025-05-01 Checkmate Pharmaceuticals Packaging oligonucleotides into virus-like particles
WO2019240503A1 (ko) * 2018-06-12 2019-12-19 주식회사 에이엠사이언스 B형 간염 예방 또는 치료용 조성물
WO2019240504A1 (en) * 2018-06-12 2019-12-19 Am Sciences Co., Ltd. Modified oligonucleotides for inhibition of target gene expression
US20250376689A1 (en) * 2021-08-31 2025-12-11 City Of Hope Oligonucleotides having 6-thio-2'-deoxyguanosine residues and uses thereof
CN113517062B (zh) * 2021-09-14 2021-12-10 青岛未来移动医疗科技有限公司 一种智能疫苗雾化系统及使用方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4469863A (en) * 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US5023243A (en) * 1981-10-23 1991-06-11 Molecular Biosystems, Inc. Oligonucleotide therapeutic agent and method of making same
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
DE4321946A1 (de) * 1993-07-01 1995-01-12 Hoechst Ag Methylphosphonsäureester, Verfahren zu deren Herstellung und deren Verwendung
US5658738A (en) * 1994-05-31 1997-08-19 Becton Dickinson And Company Bi-directional oligonucleotides that bind thrombin
EP1167378B1 (en) * 1994-07-15 2011-05-11 University of Iowa Research Foundation Immunomodulatory oligonucleotides
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
AU738513B2 (en) * 1997-02-28 2001-09-20 University Of Iowa Research Foundation, The Use of nucleic acids containing unmethylated CpG dinucleotide in the treatment of LPS-associated disorders
EP1003531B1 (en) * 1997-05-20 2007-08-22 Ottawa Health Research Institute Processes for preparing nucleic acid constructs
US6218371B1 (en) * 1998-04-03 2001-04-17 University Of Iowa Research Foundation Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
DE60014076T2 (de) * 1999-04-19 2005-10-13 Glaxosmithkline Biologicals S.A. Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
EP1220684B2 (en) 1999-09-27 2010-07-14 Coley Pharmaceutical Group, Inc. Methods related to immunostimulatory nucleic acid-induced interferon
US6949520B1 (en) 1999-09-27 2005-09-27 Coley Pharmaceutical Group, Inc. Methods related to immunostimulatory nucleic acid-induced interferon
IL160157A0 (en) 2001-08-17 2004-07-25 Coley Pharm Group Inc Combination motif immune stimulation oligonucleotides with improved activity
WO2006091915A2 (en) * 2005-02-24 2006-08-31 Coley Pharmaceutical Group, Inc. Immunostimulatory oligonucleotides
JP2008535859A (ja) * 2005-04-08 2008-09-04 コーリー ファーマシューティカル グループ，インコーポレイテッド 感染症によって悪化した喘息を治療するための方法

Also Published As

Publication number Publication date
EP2160199A2 (en) 2010-03-10
MX2009012482A (es) 2009-12-02
WO2008142509A3 (en) 2009-03-05
AR066626A1 (es) 2009-09-02
RU2009142211A (ru) 2011-05-27
AU2008252577A1 (en) 2008-11-27
CN101678098A (zh) 2010-03-24
JP2009035530A (ja) 2009-02-19
IL202096A0 (en) 2010-06-16
US20100285041A1 (en) 2010-11-11
KR20100010509A (ko) 2010-02-01
WO2008142509A2 (en) 2008-11-27
TW200916115A (en) 2009-04-16
CA2687441A1 (en) 2008-11-27
ZA200908062B (en) 2010-06-30

Similar Documents

Publication Publication Date Title
BRPI0811621A2 (pt) Oligonucleotídeos de classe a com potência imunoestimuladora, composição contendo os mesmos e uso da referida composição
BRPI0813770A2 (pt) Composição, e, uso de uma composição
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0908792A2 (pt) Composição, e, uso de uma combinação
BRPI0919193A2 (pt) Uso de lipídeo, e, composição nutricional
BRPI0810696A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0810022A2 (pt) Álcool alcoxilado, composição, e, uso de um álcool alcoxilado
BRPI0912717A2 (pt) Composição farmacêutica, e, uso de 5-azacitidina
BRPI0919014A2 (pt) composição fixadora de cabelo, e, uso de uma composição
BRPI0819350A2 (pt) Turbina eólica com rotatória hidráulica
BRPI0821276A2 (pt) Produto, e, uso do produto
BRPI0915134A2 (pt) composto, e, uso de um composto
BRPI0914793A2 (pt) Composição, e, uso de uma composição
BRPI1014316A2 (pt) composição, e, uso de uma composição
BRPI0823082A2 (pt) Uso derivados de sesquiterpeno
BRPI0720211A2 (pt) Derivado de indanona, composição, e, uso de uma composição
BRPI1013421A2 (pt) composição parasticida tópica, e, uso de uma composição
BRPI0716327A2 (pt) Composto de fenilpropionamida e uso
BRPI0918487A2 (pt) processo para a preparação de uma composição de copolímero, composição, e, uso de uma composição de copolímero
DK1973775T3 (da) Bølgeenergi
BRPI0813457A2 (pt) Composto de organoenxofre contendo halogênio e uso do mesmo
BRPI0812991A2 (pt) Utilização de combustível melhorado
ATE461253T1 (de) Antihaft-beschichtungszusammensetzung
BRPI0812942A2 (pt) Composto, composição farmacêutica e uso de um composto
BRPI0810019A2 (pt) Composto, composição farmacêutica, e, uso de um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]